[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fwfXQS0caac8ynxAxO-2P-4-ym-HWQ3oWjevvut31eAU":8,"$fJvD72qhr7_AZRIc6zoXcPO2uaPdpqbiXcNAEWNNMj3g":54,"$f1rTf3lYpLmKBz2FoYcnY70lx-t6bsKXRvz0SlJtAXRo":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":25,"views":26,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":27,"seoTitle":22,"seoKeywords":28,"seoDescription":29,"shelvesTime":30,"version":21,"menus":31,"menuId":33,"type":41,"quality":52,"commentCount":21,"isComment":41},68137,867283,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//o1oe1SwU3vlGsqy95secRlqRH2wkEV8k.png","王俊","烟台高新技术产业开发区医院","普通内科","主治医师",416,0,"宫颈癌晚期治疗用药全指南：化疗与靶向药物实用细节解析","","https://ystcdn.venuertc.com/venue/AI/9d3b219c-eaed-4fdf-84f4-0b4a14a5b8e2.jpg","\u003Cdiv class=\"material-article__wrapper\">\n  \u003Ch1 id=\"material_title\" class=\"material-article__main-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">宫颈癌晚期治疗用药全指南：化疗与靶向药物实用细节解析\u003C/h1>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-section__header material-section__header-bg1\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 什么药？化疗与靶向药的基本认识 🩺\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-section__content\">\n      \u003Cp>\n        现实中，化疗药与靶向药是宫颈癌晚期常见的药物方案。化疗药通常为注射剂型，部分可为口服制剂，常见成分包含紫杉醇、顺铂等。靶向药多为口服片剂或注射剂，例如贝伐珠单抗等。\u003Cbr>\n        \u003Cbr>\n        化疗药作用方式为抑制异常细胞分裂，阻断细胞扩增。靶向药则精准干扰肿瘤细胞的特定分子信号通路，影响肿瘤血管生成或抑制特殊受体活性。两类药物常见于联合使用，以增强疗效。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>化疗药常见剂型：静脉注射溶液、口服片剂\u003C/li>\n        \u003Cli>靶向药剂型：口服片剂（常规）、注射剂（部分通用）\u003C/li>\n        \u003Cli>常见成分：紫杉醇、顺铂（化疗）；贝伐珠单抗、帕博利珠单抗（靶向）\u003C/li>\n        \u003Cli>联合应用时，用药顺序与时间应严格遵医嘱\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cem>引用文献：\u003C/em> Tewari KS, Sill MW, Long HJ, et al. \"Improved survival with bevacizumab in advanced cervical cancer.\" N Engl J Med. 2014;370(8):734-743.\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-section__header material-section__header-bg2\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 如何正确使用？用药时间、方法与剂量 ⏰💊\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-section__content\">\n      \u003Cp>\n        化疗药通常由专业医护人员静脉滴注给药，根据方案1-3周为一周期。部分口服辅助化疗药可每日或按周期内固定天数服用。靶向药以口服为主，多数每日一次，推荐与水送服，服药时间可根据具体药品说明调整。在特殊情况下，部分靶向药需隔一定时间与其他药物间隔服用。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>静脉化疗：由医护人员操作，患者需按时就诊。\u003C/li>\n        \u003Cli>口服化疗药或靶向药：按说明或医嘱整片吞服，不建议掰开、咀嚼。\u003C/li>\n        \u003Cli>服药间隔：如配合多种药品，应遵医嘱设置服药间隔，部分靶向药需在进食前后特定时间服用。\u003C/li>\n        \u003Cli>漏服处理：若忆起漏服，尽快补服。当接近下一次服药时间时，直接按计划服用，不可一次性补足多剂。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>正确做法：\u003C/strong>用量需精确，严禁自行增减剂量。部分药物需随血常规等检查调整剂量。若有不适，立即咨询医生。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>案例：一位老年患者接受多周期联合化疗，按照指定时间服药，药物耐受性良好，副作用可控。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-section__header material-section__header-bg3\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药物相互作用须知道⚠️\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-section__content\">\n      \u003Cp>\n        不同药物间存在相互作用风险。部分化疗药与其他静脉药品同用时可能加重毒副作用。靶向药与某些抗高血压药、抗凝血药、抗酸药等同时服用，也可能降低疗效或增加不良反应。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>化疗药常见相互作用：与氨基糖苷类抗生素、环孢素合用，肾毒性风险上升\u003C/li>\n        \u003Cli>靶向药常见相互作用：与阿司匹林、华法林等抗凝血药同用出血风险升高\u003C/li>\n        \u003Cli>与抗酸药联合：会影响部分靶向药生物利用度，建议间隔2小时以上\u003C/li>\n        \u003Cli>草药、保健品也可能影响药效或引起不良反应\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>特别提醒：\u003C/strong>新服用或停用任一药品前，请务必咨询医生或药师。有些药物可能需要通过调整时间或剂量来避免不良相互作用。\n      \u003C/p>\n      \u003Cp>\n        \u003Cem>引用文献：\u003C/em> Cohen MH, Johnson JR, Chen YF, et al. \"FDA drug approval summary: bevacizumab (Avastin) plus carboplatin and paclitaxel as first-line treatment of advanced/metastatic nonsmall cell lung cancer.\" Oncologist. 2007;12(6):713–718.\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-section__header material-section__header-bg4\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 常见不良反应：识别与处理🩸\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-section__content\">\n      \u003Cp>\n        服用化疗或靶向药期间，较常见的副作用包括骨髓抑制、乏力、口腔溃疡、胃肠反应、皮肤改变等。骨髓抑制表现为白细胞、血小板减少，需要定期检测血常规。部分靶向药可能造成高血压、出血、蛋白尿等。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>骨髓抑制（白细胞、血小板减少）：建议每次用药前后查血，监测数值，如异常及时告知医生。\u003C/li>\n        \u003Cli>恶心、呕吐：按需服用止吐药，可少量多餐，饮食清淡。\u003C/li>\n        \u003Cli>皮肤反应（如皮疹或色素沉着）：保持皮肤清洁，避免太阳直晒。\u003C/li>\n        \u003Cli>口腔溃疡、口干：使用无刺激性漱口水，保持口腔卫生。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>出现异常怎么办？\u003C/strong>如持续高热、皮疹严重、口腔及肛周出血、极度乏力，需立刻就医。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>临床上使用顺铂联合贝伐珠单抗时，部分患者出现一过性白细胞下降，经专业对症处理后恢复。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cem>引用文献：\u003C/em> Pfaender S, et al. \"Tolerability profile of bevacizumab: a pooled analysis of controlled trials in advanced solid cancers.\" Eur J Cancer. 2012;48(6):783-796.\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-section__header material-section__header-bg5\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 特殊人群用药指南 👵👨‍⚕️\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-section__content\">\n      \u003Cul>\n        \u003Cli>\u003Cb>老年人：\u003C/b>肝肾功能下降时，部分化疗药或靶向药需减量，具体由医生根据化验结果调整。\u003C/li>\n        \u003Cli>\u003Cb>肝肾功能不全：\u003C/b>部分药物（如顺铂）主要经肾代谢，肾功能损害时须慎用或调整剂量。\u003C/li>\n        \u003Cli>\u003Cb>孕妇与哺乳期女性：\u003C/b>绝大多数化疗药和靶向药禁止在妊娠与哺乳期间使用，避免对胎儿和婴儿造成伤害。\u003C/li>\n        \u003Cli>\u003Cb>儿童：\u003C/b>目前靶向药在儿童中的应用较少，化疗剂量需根据体重或体表面积严格计算。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>建议：\u003C/strong>若有特殊体质，务必向医生说明，按个体化方案用药。定期复查肝肾功能，按检查结果调整用药计划。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>有位患者在接受维持性化疗时，由于肾功能轻度下降，经减量治疗，顺利完成疗程。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-section__header material-section__header-bg6\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 储存与过期处理 🔒\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-section__content\">\n      \u003Cp>\n        适当存储药品，有助于保证疗效与安全。化疗与靶向药常见两类储存条件：\u003Cbr>\n        \u003C/p>\u003Cul>\n          \u003Cli>室温（\u003Cb>15-30℃\u003C/b>）保存，避免阳光直射、高温、潮湿。\u003C/li>\n          \u003Cli>部分注射药品需冷藏（\u003Cb>2-8℃\u003C/b>），但勿冷冻，并避免反复取出放回。\u003C/li>\n        \u003C/ul>\n        \u003Cbr>\n        \u003Cstrong>过期药品处理：\u003C/strong>过期、变质的化疗及靶向药严禁自行服用，应送到药店或指定医疗废弃点统一销毁。切勿随垃圾丢弃，以免危害他人和环境。\n      \u003Cp>\u003C/p>\n      \u003Cul>\n        \u003Cli>药品取出服用后，药瓶或药盒应密封保存。\u003C/li>\n        \u003Cli>开封的注射剂如24小时内未用尽，需按说明丢弃。\u003C/li>\n        \u003Cli>药品如出现颜色、性质变化，立即停用。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"material-section\">\n    \u003Cdiv class=\"material-section__header material-section__header-bg7\">\n      \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药品的优势与注意要点总结 🏆\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"material-section__content\">\n      \u003Cul>\n        \u003Cli>化疗药能快速抑制异常细胞增殖，短期控制病情效果显著。\u003C/li>\n        \u003Cli>靶向药副作用相对较低，对生活影响较小，适于长期维持。\u003C/li>\n        \u003Cli>联合应用时可发挥协同效应，但需密切监测血象、生化指标。\u003C/li>\n        \u003Cli>用药期间严格遵医嘱调整剂量和周期，勿擅自更改方案。\u003C/li>\n        \u003Cli>日常生活中避免接触感染源，保证营养和充足休息，有助于耐受治疗。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-section__summary\">\n        \u003Cstrong>结语：\u003C/strong>\n        用药规范、安全，是提升治疗效果的第一步。务必定时随访、按计划检测，出现严重不良反应或疑问时，及时向医生或药师咨询。切勿因为副作用自行停药或减药，把健康主动权掌握在自己手中。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Cfooter class=\"material-article__footer\">\n    \u003Ch3 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">主要参考文献\u003C/h3>\n    \u003Col>\n      \u003Cli>Tewari KS, Sill MW, Long HJ, et al. Improved survival with bevacizumab in advanced cervical cancer.\u003Cem> N Engl J Med. \u003C/em>2014;370(8):734-743. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24552320/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n      \u003Cli>Cohen MH, Johnson JR, Chen YF, et al. FDA drug approval summary: bevacizumab (Avastin) plus carboplatin and paclitaxel as first-line treatment of advanced/metastatic nonsmall cell lung cancer. \u003Cem>Oncologist.\u003C/em> 2007;12(6):713–718. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/17602065/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n      \u003Cli>Pfaender S, et al. Tolerability profile of bevacizumab: a pooled analysis of controlled trials in advanced solid cancers. \u003Cem>Eur J Cancer.\u003C/em> 2012;48(6):783-796. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22133797/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n    \u003C/ol>\n  \u003C/footer>\n\u003C/div>\n\n\u003Cstyle>\n.material-article__wrapper {\n  font-family: 'PingFang SC', 'Microsoft YaHei', Arial, sans-serif;\n  color: #353A3F;\n  max-width: 820px;\n  background: #ffffff;\n  margin: 48px auto;\n  border-radius: 10px;\n  border: 1px solid #e0e3ea;\n  box-shadow: 0 2px 8px 0 rgba(159,173,194,0.10);\n  padding: 32px 36px 18px 36px;\n  box-sizing: border-box;\n}\n\n.material-article__main-title {\n  font-size: 2.1em;\n  color: #244268;\n  letter-spacing: 2px;\n  text-align: center;\n  font-weight: 700;\n  margin: 0 0 34px 0;\n  padding-top: 8px;\n}\n\n.material-section {\n  margin-bottom: 38px;\n}\n\n/* 淡雅头图背景，仅色彩，不用image */\n.material-section__header {\n  border-radius: 8px 8px 0 0;\n  padding: 11px 21px 12px 19px;\n  font-size: 1.35em;\n  font-weight: 600;\n  margin-bottom: 0;\n  background-size: cover;\n  color: #21406F;\n  letter-spacing: 0.5px;\n}\n\n.material-section__header-bg1 { background: linear-gradient(90deg,#e5edf5 0%,#f7fafd 100%);}\n.material-section__header-bg2 { background: linear-gradient(90deg,#f5ebe5 0%,#fcfcfd 100%);}\n.material-section__header-bg3 { background: linear-gradient(90deg,#e5f6ef 0%,#fcfcfc 100%);}\n.material-section__header-bg4 { background: linear-gradient(90deg,#fdf6e5 0%,#fffefd 100%);}\n.material-section__header-bg5 { background: linear-gradient(90deg,#e6eaf7 0%,#f4f8fd 100%);}\n.material-section__header-bg6 { background: linear-gradient(90deg,#f0f7e6 0%,#f8fdf4 100%);}\n.material-section__header-bg7 { background: linear-gradient(90deg,#f6eefb 0%,#fcfcfc 100%);}\n\n.material-section__content {\n  background: #f9fafb;\n  border-radius: 0 0 8px 8px;\n  padding: 18px 19px 6px 23px;\n  font-size: 1.09em;\n  line-height: 2.0em;\n  margin-top: 0px;\n}\n\n.material-section__content ul {\n  margin: 11px 0 16px 0;\n  padding-left: 20px;\n}\n\n.material-section__content ul li {\n  margin-bottom: 8px;\n  font-size: 1em;\n  list-style-type: disc;\n}\n\n.material-section__content strong {\n  color: #3366bb;\n}\n\n.material-section__summary {\n  margin: 1.5em 0 0.8em 0;\n  padding: 13px 20px;\n  background: #edf4fa;\n  border-radius: 6px;\n  color: #354670;\n  text-align: left;\n  font-size: 1.13em;\n}\n\n.material-article__footer {\n  margin: 37px 0 6px 0;\n  border-top: 1px solid #e6eaf6;\n  padding-top: 22px;\n  background: #f8fafd;\n  border-radius: 0 0 10px 10px;\n}\n\n.material-article__footer h3 {\n  color: #23519a;\n  font-size: 1.1em;\n  margin-bottom: 13px;\n  font-weight: bold;\n}\n\n.material-article__footer ol {\n  margin: 0 0 0 22px;\n  padding-left: 0;\n  color: #4C4D50;\n  font-size: 0.99em;\n}\n\n.material-article__footer ol li {\n  margin-bottom: 7px;\n}\n\n@media (max-width: 650px) {\n  .material-article__wrapper {\n    padding: 12px 3% 14px 3%;\n    max-width: 99vw;\n    margin: 10px 0;\n  }\n  .material-article__main-title {\n    font-size: 1.25em;\n    padding-top: 4px;\n  }\n  .material-section__header {\n    font-size: 1.07em;\n    padding: 8px 6px 10px 8px;\n  }\n  .material-section__content {\n    padding: 9px 6px 2px 10px;\n    font-size: 0.95em;\n  }\n  .material-section__summary {\n    padding: 7px 9px;\n    font-size: 0.95em;\n  }\n  .material-article__footer {\n    padding-top: 11px;\n  }\n}\n\u003C/style>\n\n",514,"2025-10-21 16:38:18","宫颈癌,化疗药,靶向药,治疗用药,不良反应,老年患者,药物相互作用,药物使用指南","本文提供了针对宫颈癌晚期治疗的全面用药指南，涵盖化疗与靶向药物的使用方法与注意事项，帮助患者及其家属有效管理治疗过程。","2025-10-21 17:19:31",[32],{"menuId":33,"menuName":34,"parentId":21,"orderNum":35,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":21,"createDept":6,"remark":23,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":21,"forceLogin":21,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普",2,"article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]